Ten-year follow-up of eyes treated with stereotactic fractionated external beam radiation for neovascular age-related macular degeneration

Retina

Volumn 31, Issue 7, 2011, Pages 1303-1315

  Trikha, Rupan ^a   Morse, Lawrence S ^a   Zawadzki, Robert J ^a   Werner, John S ^a   Park, Susanna S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

age related macular degeneration; exudative age related macular degeneration; geographic atrophy; neovascular age related macular degeneration; radiation; radiation retinopathy

Indexed keywords

ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; NEOVASCULAR GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; RADIATION EXPOSURE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; DOSE FRACTIONATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOURIER ANALYSIS; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 79961207823     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318203ee46     Document Type: Article

References (42)

1. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al; VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascularization age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
2. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431. (Pubitemid 44511557)
3. Avila MP, Farah ME, Santos A, et al. Twelve-month short-term safety and visual-acuity results from a multicenter prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Br J Ophthalmol 2009;93:305-309.
4. Archambeau JO, Mao XW, Yonemoto LT, et al. What is the role of radiation in the treatment of subfoveal membranes: review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion. Int J Radiat Oncol Biol Phys 1998;40:1125-1136. (Pubitemid 28152928)
5. Monroe AT, Bhandare N, Morris CG, Mendenhali WM. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005;61:856-864. (Pubitemid 40247982)
6. Marcus DM, Sheils WC, Johnson MH, et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration. Arch Ophthalmol 2001;119:171-180.
7. Barak A, Hauser D, Yipp P, et al. A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration. Br J Radiol 2005;78:827-831. (Pubitemid 41246152)
8. Flaxel CJ, Friedrichsen EJ, Smith JO, et al. Proton beam irradiation of subfoveal choroidal neovascularization in agerelated macular degeneration. Eye 2000;14:155-164. (Pubitemid 30265161)
9. Ciulla TA, Danis RP, Klein SB, et al. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial. Am J Ophthalmol 2002;134: 905-906. (Pubitemid 35425461)
10. Marcus DM, Peskin E, AMDRT Research Group. The agerelated macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study. Am J Ophthalmol 2004;138: 818-828. (Pubitemid 39452930)
11. Hart PM, Chakravarthy U, Mackenzie G, et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 2002;120:1029-1038. (Pubitemid 34856070)
12. Radiation Therapy for Age-Related Macular Degeneration (RAD) Group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology 1999;106: 2239-2247.
13. Spaide RF, Guyer DR, McMormic B, et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30. (Pubitemid 28070598)
14. Chakravarthy U, Mackenzie G. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. Br J Radiol 2000;73:305-313. (Pubitemid 30192804)
15. Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2004; 18: CD004004.
16. Prettenhofer U, Haas A, Mayer R, et al. Long-term results after external radiotherapy for age-related macular degeneration. Strahlenther Onkol 2004;180:91-95. (Pubitemid 38165880)
17. Finger PT, Gelman YP, Berson AM, Szechter A. Palladium- 103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol 2003;87:1497-1503. (Pubitemid 38010556)
18. Churei H, Ohkubo K, Nakajo M, et al. External-beam radiation therapy for age-related macular degeneration: two years' follow-up at a total dose of 20 Gy in 10 fractions. Radiat Med 2004;22:398-404. (Pubitemid 40144017)
19. Bergink GJ, Hoyng CB, Van der Maazen RW, et al. A randomized controlled trial of efficacy of radiation therapy in the control of subfoveal neovascularization in age-related macular degeneration: radiation versus observation. Graefes Arch Clin Exp Ophthalmol 1998;236:321-325. (Pubitemid 28192831)
20. Valmaggia C, Ries G, Ballinari P. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Am J Ophthalmol 2002;133:521-529. (Pubitemid 34258061)
21. Char DH, Irvine AI, Posner MD, et al. Randomized trial of radiation for age-related macular degeneration. Am J Ophthalmol 1999;127:574-578. (Pubitemid 29215769)
22. Kobayashi H, Kobayashi K. Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophthalmol 2000;130:617-635.
23. Zambarakji HJ, Lane AM, Ezra E, et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology 2006;113:2012-2019. (Pubitemid 44635705)
24. Yonemoto LT, Slater JD, Friedrichsen EJ, et al. Treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results. Int J Radiat Oncol Biol Phys 1996;36:867-871. (Pubitemid 27008602)
25. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation retinopathy after external-beam radiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-773. (Pubitemid 24355923)
26. Takeda A, Shigematsu N, Suzuki S, et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 1999;44:599-605. (Pubitemid 29258435)
27. Flaxel CJ. Use of radiation in the treatment of age-related macular degeneration. Ophthalmol Clin North Am 2002;15: 437-444. (Pubitemid 36076598)
28. Guyer DR, Mukai S, Egan KM, et al. Radiation maculopathy following proton beam irradiation for choroidal melanoma. Ophthalmology 1992;99:1278-1285.
29. Smith AJ, Telander DG, Zawadzki RJ, et al. High-resolution Fourier-domain optical coherence tomography and microperimetric findings after macular-off retinal detachment repair. Ophthalmology 2008;115:1923-1929.
30. Stopa M, Bower BA, Davies E, et al. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina 2008;28:298-308. (Pubitemid 351643161)
31. Takahashi K, Kishi S, Muraoka K, et al. Radiation choroidopathy with remodeling of the choroidal venous system. Am J Ophthalmol 1998;125:367-373. (Pubitemid 28124366)
32. Amoaku WM, Lafaut B, Sallet G, De Laey JJ. Radiation choroidal vasculopathy: an indocyanine green angiography study. Eye 1995;9:738-744. (Pubitemid 26018199)
33. Egbert PR, Fajardo LF, Donaldson SS, et al. Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study. Br J Ophthalmol 1980;64:660-665. (Pubitemid 10020920)
34. Williams GR, Lett JT. Damage to the photoreceptor cells of the rabbit retina from 56 Fe ions: effect of age at exposure. Adv Space Res 1996;18:55-58.
35. Lett JT, Williams GR. Effects of linear energy transfer on the formation and fate of radiation damage to the photoreceptor cell complement of the rabbit retina: implications for the projected manned mission to mars. In: Swenberg CE, ed. Biological effects and physics of solar and galactic cosmic radiation, Part A. New York, Plenum Press, 177-184 (1993).
36. Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol 2008;146:692-699.
37. Wolf-Schnurrbusch UEK, Enzmann V, Brinkmann CK,Wolf S. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci 2008;49:3095-3099.
38. Fleckenstein M, Issa PC, Helb H, et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:4137-4144.
39. Brown DM, Michels M, Kaiser PK, et al; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular are-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009;116:57-65.
40. Brown GD, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-1501. (Pubitemid 13217693)
41. Finger PT, Berson A, Ng T, et al. Ophthalmic plaque radiation therapy for age-related macular degeneration association with subretinal neovascularization. Am J Ophthalmol 1999;127:170-177. (Pubitemid 29072557)
42. Berson A, Finger PT, Chakravarthy U. Radiation therapy for age-related macular degeneration. Semin Radiat Oncol 1999;9: 155-162. (Pubitemid 29187968)